APA (7th ed.) Citation

Stapleton, J. T., Wagner, N., Tuetken, R., Bellamy, A. R., Hill, H., Kim, S., & Winokur, P. L. (2020). High dose trivalent influenza vaccine compared to standard dose vaccine in patients with rheumatoid arthritis receiving TNF-alpha inhibitor therapy and healthy controls: Results of the DMID 10-0076 randomized clinical trial. Vaccine, 38(23), 3934. https://doi.org/10.1016/j.vaccine.2020.04.002

Chicago Style (17th ed.) Citation

Stapleton, Jack T., Nancy Wagner, Rebecca Tuetken, Abbie R. Bellamy, Heather Hill, Sonnie Kim, and Patricia L. Winokur. "High Dose Trivalent Influenza Vaccine Compared to Standard Dose Vaccine in Patients with Rheumatoid Arthritis Receiving TNF-alpha Inhibitor Therapy and Healthy Controls: Results of the DMID 10-0076 Randomized Clinical Trial." Vaccine 38, no. 23 (2020): 3934. https://doi.org/10.1016/j.vaccine.2020.04.002.

MLA (9th ed.) Citation

Stapleton, Jack T., et al. "High Dose Trivalent Influenza Vaccine Compared to Standard Dose Vaccine in Patients with Rheumatoid Arthritis Receiving TNF-alpha Inhibitor Therapy and Healthy Controls: Results of the DMID 10-0076 Randomized Clinical Trial." Vaccine, vol. 38, no. 23, 2020, p. 3934, https://doi.org/10.1016/j.vaccine.2020.04.002.